WORLD
U.S. FDA Declines to Approve Lilly/Innovent Lung Cancer Drug - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'U.S. FDA declines to approve Lilly/Innovent lung cancer drug ...'
U.S. FDA declines to approve Lilly/Innovent lung cancer drug https://t.co/mq6JGbAYdY pic.twitter.com/fZ1F4ONzfK— Reuters (@Reuters) March 24, 2022
(The above story first appeared on LatestLY on Mar 24, 2022 09:49 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
